716 related articles for article (PubMed ID: 8871677)
21. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice.
Chatenoud L; Primo J; Bach JF
J Immunol; 1997 Mar; 158(6):2947-54. PubMed ID: 9058834
[TBL] [Abstract][Full Text] [Related]
22. Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice.
Martin S; van den Engel NK; Vinke A; Heidenthal E; Schulte B; Kolb H
J Autoimmun; 2001 Sep; 17(2):109-17. PubMed ID: 11591119
[TBL] [Abstract][Full Text] [Related]
23. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
Tisch R; Wang B; Serreze DV
J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
[TBL] [Abstract][Full Text] [Related]
24. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
25. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
26. Dietary protection against diabetes in NOD mice: lack of a major change in the immune system.
Hermitte L; Atlan-Gepner C; Payan MJ; Mehelleb M; Vialettes B
Diabete Metab; 1995 Oct; 21(4):261-8. PubMed ID: 8529761
[TBL] [Abstract][Full Text] [Related]
27. Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.
Schloot NC; Daniel D; Norbury-Glaser M; Wegmann DR
J Autoimmun; 1996 Jun; 9(3):357-63. PubMed ID: 8816971
[TBL] [Abstract][Full Text] [Related]
28. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
29. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse.
Balasa B; Van Gunst K; Jung N; Katz JD; Sarvetnick N
Cell Immunol; 2000 Jun; 202(2):97-102. PubMed ID: 10896769
[TBL] [Abstract][Full Text] [Related]
30. T cells to a dominant epitope of GAD65 express a public CDR3 motif.
Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E
Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice.
Yagi H; Matsumoto M; Kunimoto K; Kawaguchi J; Makino S; Harada M
Eur J Immunol; 1992 Sep; 22(9):2387-93. PubMed ID: 1516628
[TBL] [Abstract][Full Text] [Related]
32. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
[TBL] [Abstract][Full Text] [Related]
33. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
[TBL] [Abstract][Full Text] [Related]
34. Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice.
Kimura T; Ito A; Hancock WW; Maki T
J Autoimmun; 1999 Jun; 12(4):243-9. PubMed ID: 10330295
[TBL] [Abstract][Full Text] [Related]
35. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
[TBL] [Abstract][Full Text] [Related]
36. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
Mathieu C; Casteels K; Bouillon R; Waer M
J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
[TBL] [Abstract][Full Text] [Related]
37. Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12.
Miyaguchi S; Satoh J; Takahashi K; Sakata Y; Nakazawa T; Miyazaki J; Toyota T
Clin Immunol; 2001 Jan; 98(1):119-24. PubMed ID: 11141334
[TBL] [Abstract][Full Text] [Related]
38. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1.
Nakazawa T; Satoh J; Takahashi K; Sakata Y; Ikehata F; Takizawa Y; Bando SI; Housai T; Li Y; Chen C; Masuda T; Kure S; Kato I; Takasawa S; Taniguchi T; Okamoto H; Toyota T
J Autoimmun; 2001 Sep; 17(2):119-25. PubMed ID: 11591120
[TBL] [Abstract][Full Text] [Related]
39. Induction of T cell tolerance by pretreatment with anti-ICAM-1 and anti-lymphocyte function-associated antigen-1 antibodies prevents antigen-induced eosinophil recruitment into the mouse airways.
Nakao A; Nakajima H; Tomioka H; Nishimura T; Iwamoto I
J Immunol; 1994 Dec; 153(12):5819-25. PubMed ID: 7989777
[TBL] [Abstract][Full Text] [Related]
40. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
